By Annie Lennon, Nov 30, 2022
Dr. Kecia Gaither, MPH, FACOG, double board certified OB-GYN and maternal fetal medicine specialist and director of Perinatal Services and Maternal Fetal Medicine at NYC Health + Hospitals/Lincoln in New York City, not involved in the study, explained another key limitation of the study to MNT: “The biggest limitation is that only 80% of pathogenic bacteria are impacted by this developed vaccine; with pathogens like staphylococcus, klebsiella, proteus, and pseudomonas, limited efficacy exists.”
Click HERE for the full article.
